| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.26 | 2e-08 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-07 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |